spacer
spacer

PDBsum entry 1vse

Go to PDB code: 
protein ligands links
Endoribonuclease PDB id
1vse

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
146 a.a. *
Ligands
EPE
Waters ×124
* Residue conservation analysis
PDB id:
1vse
Name: Endoribonuclease
Title: Asv integrase core domain with mg(ii) cofactor and hepes ligand, low mg concentration form
Structure: Integrase. Chain: a. Fragment: catalytic core domain, residues 1 - 4, 52 - 209. Engineered: yes. Other_details: crystals soaked in 20 millimoilar mgcl2
Source: Rous sarcoma virus (strain schmidt-ruppin). Organism_taxid: 11889. Strain: schmidt-ruppin. Expressed in: escherichia coli. Expression_system_taxid: 562. Other_details: original viral DNA clone\: ju et al., J. Virol. 33:1026-1033 (1980), original expression clone\: terry et al., J. Virol. 62:2358-2365 (1988), expression clone for core\: kulkosky et al., J. Virol. 206:448-456 (1995)
Biol. unit: Dimer (from PDB file)
Resolution:
2.20Å     R-factor:   0.138     R-free:   0.201
Authors: G.Bujacz,M.Jaskolski,J.Alexandratos,A.Wlodawer
Key ref:
G.Bujacz et al. (1996). The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure, 4, 89-96. PubMed id: 8805516 DOI: 10.1016/S0969-2126(96)00012-3
Date:
29-Nov-95     Release date:   03-Apr-96    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
O92956  (POL_RSVSB) -  Gag-Pol polyprotein from Rous sarcoma virus subgroup B (strain Schmidt-Ruppin)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1603 a.a.
146 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class 2: E.C.2.7.7.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 3: E.C.2.7.7.49  - RNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 4: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 5: E.C.3.1.-.-
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 6: E.C.3.1.26.4  - ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Endonucleolytic cleavage to 5'-phosphomonoester.
   Enzyme class 7: E.C.3.4.23.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/S0969-2126(96)00012-3 Structure 4:89-96 (1996)
PubMed id: 8805516  
 
 
The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations.
G.Bujacz, M.Jaskólski, J.Alexandratos, A.Wlodawer, G.Merkel, R.A.Katz, A.M.Skalka.
 
  ABSTRACT  
 
BACKGROUND: Members of the structurally-related superfamily of enzymes that includes RNase H, RuvC resolvase, MuA transposase, and retroviral integrase require divalent cations for enzymatic activity. So far, cation positions are reported in the X-ray crystal structures of only two of these proteins, E. coli and human immunodeficiency virus 1 (HIV-1) RNase H. Details of the placement of metal ions in the active site of retroviral integrases are necessary for the understanding of the catalytic mechanism of these enzymes. RESULTS: The structure of the enzymatically active catalytic domain (residues 52-207) of avian sarcoma virus integrase (ASV IN) has been solved in the presence of divalent cations (Mn2+ or Mg2+), at 1.7-2.2 A resolution. A single ion of either type interacts with the carboxylate groups of the active site aspartates and uses four water molecules to complete its octahedral coordination. The placement of the aspartate side chains and metal ions is very similar to that observed in the RNase H members of this superfamily; however, the conformation of the catalytic aspartates in the active site of ASV IN differs significantly from that reported for the analogous residues in HIV-1 IN. CONCLUSIONS: Binding of the required metal ions does not lead to significant structural modifications in the active site of the catalytic domain of ASV IN. This indicates that at least one metal-binding site is preformed in the structure, and suggests that the observed constellation of the acidic residues represents a catalytically competent active site. Only a single divalent cation was observed even at extremely high concentrations of the metals. We conclude that either only one metal ion is needed for catalysis, or that a second metal-binding site can only exist in the presence of substrate and/or other domains of the protein. The unexpected differences between the active sites of ASV IN and HIV-1 IN remain unexplained; they may reflect the effects of crystal contacts on the active site of HIV-1 IN, or a tendency for structural polymorphism.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. Chain tracing of the catalytic domain of ASV IN, showing the secondary structure elements and the location of the active site. Figure 1. Chain tracing of the catalytic domain of ASV IN, showing the secondary structure elements and the location of the active site. (Figure prepared using the program RIBBONS [[3]33].)
Figure 2.
Figure 2. Active site of the catalytic domain of ASV IN. (a) Stereoview of the electron-density map (generated using O [34]) for the Mg^2+ complex (500 mM MgCl[2], see text). This F[o]–F[c] map, contoured at 5σ level, was calculated at 1.8 å resolution after refinement of a model which excluded the Mg^2+ cation and its coordinated water molecules. The density corresponding to the cluster of an octahedrally-coordinated metal ion and four waters is exceedingly clear. (b) Stereoview of the active site of ASV IN generated using MOLSCRIPT [35]. Shown is part of the active site displaying the coordination of Mn^2+ with four water molecules, as well as with the carboxylates of Asp121 and Asp64. The water molecule marked W324 is found in the same location in all ASV IN structures. The putative hydrogen bonds made by this molecule (red dashed lines), identified by an analysis of distances and angles, form a distorted tetrahedron (also including a bond to Nε2 of Gln153, not marked). Figure 2. Active site of the catalytic domain of ASV IN. (a) Stereoview of the electron-density map (generated using O [[4]34]) for the Mg^2+ complex (500 mM MgCl[2], see text). This F[o]–F[c] map, contoured at 5σ level, was calculated at 1.8 å resolution after refinement of a model which excluded the Mg^2+ cation and its coordinated water molecules. The density corresponding to the cluster of an octahedrally-coordinated metal ion and four waters is exceedingly clear. (b) Stereoview of the active site of ASV IN generated using MOLSCRIPT [[5]35]. Shown is part of the active site displaying the coordination of Mn^2+ with four water molecules, as well as with the carboxylates of Asp121 and Asp64. The water molecule marked W324 is found in the same location in all ASV IN structures. The putative hydrogen bonds made by this molecule (red dashed lines), identified by an analysis of distances and angles, form a distorted tetrahedron (also including a bond to Nε2 of Gln153, not marked).
 
  The above figures are reprinted by permission from Cell Press: Structure (1996, 4, 89-96) copyright 1996.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19937113 Z.Hobaika, L.Zargarian, R.G.Maroun, O.Mauffret, T.R.Burke, and S.Fermandjian (2010).
HIV-1 integrase and virus and cell DNAs: complex formation and perturbation by inhibitors of integration.
  Neurochem Res, 35, 888-893.  
19036793 E.Valkov, S.S.Gupta, S.Hare, A.Helander, P.Roversi, M.McClure, and P.Cherepanov (2009).
Functional and structural characterization of the integrase from the prototype foamy virus.
  Nucleic Acids Res, 37, 243-255.
PDB code: 3dlr
19119323 H.Merad, H.Porumb, L.Zargarian, B.René, Z.Hobaika, R.G.Maroun, O.Mauffret, and S.Fermandjian (2009).
An unusual helix turn helix motif in the catalytic core of HIV-1 integrase binds viral DNA and LEDGF.
  PLoS ONE, 4, e4081.  
19490099 M.Jaskolski, J.N.Alexandratos, G.Bujacz, and A.Wlodawer (2009).
Piecing together the structure of retroviral integrase, an important target in AIDS therapy.
  FEBS J, 276, 2926-2946.  
19609359 S.Hare, F.Di Nunzio, A.Labeja, J.Wang, A.Engelman, and P.Cherepanov (2009).
Structural basis for functional tetramerization of lentiviral integrase.
  PLoS Pathog, 5, e1000515.
PDB codes: 3hpg 3hph
16511570 J.M.Richardson, A.Dawson, N.O'Hagan, P.Taylor, D.J.Finnegan, and M.D.Walkinshaw (2006).
Mechanism of Mos1 transposition: insights from structural analysis.
  EMBO J, 25, 1324-1334.
PDB code: 2f7t
  16790058 J.Ramcharan, D.M.Colleluori, G.Merkel, M.D.Andrake, and A.M.Skalka (2006).
Mode of inhibition of HIV-1 Integrase by a C-terminal domain-specific monoclonal antibody.
  Retrovirology, 3, 34.  
17085478 T.L.Diamond, and F.D.Bushman (2006).
Role of metal ions in catalysis by HIV integrase analyzed using a quantitative PCR disintegration assay.
  Nucleic Acids Res, 34, 6116-6125.  
15764656 A.Brigo, K.W.Lee, G.Iurcu Mustata, and J.M.Briggs (2005).
Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain.
  Biophys J, 88, 3072-3082.  
15855529 B.Ason, D.J.Knauss, A.M.Balke, G.Merkel, A.M.Skalka, and W.S.Reznikoff (2005).
Targeting Tn5 transposase identifies human immunodeficiency virus type 1 inhibitors.
  Antimicrob Agents Chemother, 49, 2035-2043.  
15634344 J.Snásel, Z.Krejcík, V.Jencová, I.Rosenberg, T.Ruml, J.Alexandratos, A.Gustchina, and I.Pichová (2005).
Integrase of Mason-Pfizer monkey virus.
  FEBS J, 272, 203-216.  
15958388 M.Li, and R.Craigie (2005).
Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration.
  J Biol Chem, 280, 29334-29339.  
14999095 C.Calmels, V.R.de Soultrait, A.Caumont, C.Desjobert, A.Faure, M.Fournier, L.Tarrago-Litvak, and V.Parissi (2004).
Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.
  Nucleic Acids Res, 32, 1527-1538.  
15102449 M.Steiniger-White, I.Rayment, and W.S.Reznikoff (2004).
Structure/function insights into Tn5 transposition.
  Curr Opin Struct Biol, 14, 50-57.
PDB code: 1mus
15242410 V.L.Brandt, and D.B.Roth (2004).
V(D)J recombination: how to tame a transposase.
  Immunol Rev, 200, 249-260.  
12610159 A.L.Harper, M.Sudol, and M.Katzman (2003).
An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.
  J Virol, 77, 3838-3845.  
12424243 G.Peterson, and W.Reznikoff (2003).
Tn5 transposase active site mutations suggest position of donor backbone DNA in synaptic complex.
  J Biol Chem, 278, 1904-1909.  
12888514 I.Lee, and R.M.Harshey (2003).
Patterns of sequence conservation at termini of long terminal repeat (LTR) retrotransposons and DNA transposons in the human genome: lessons from phage Mu.
  Nucleic Acids Res, 31, 4531-4540.  
11997448 J.A.Grobler, K.Stillmock, B.Hu, M.Witmer, P.Felock, A.S.Espeseth, A.Wolfe, M.Egbertson, M.Bourgeois, J.Melamed, J.S.Wai, S.Young, J.Vacca, and D.J.Hazuda (2002).
Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes.
  Proc Natl Acad Sci U S A, 99, 6661-6666.  
11805085 J.Yi, H.Cheng, M.D.Andrake, R.L.Dunbrack, H.Roder, and A.M.Skalka (2002).
Mapping the epitope of an inhibitory monoclonal antibody to the C-terminal DNA-binding domain of HIV-1 integrase.
  J Biol Chem, 277, 12164-12174.  
11462051 A.L.Harper, L.M.Skinner, M.Sudol, and M.Katzman (2001).
Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection.
  J Virol, 75, 7756-7762.  
11743009 J.Y.Wang, H.Ling, W.Yang, and R.Craigie (2001).
Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.
  EMBO J, 20, 7333-7343.
PDB code: 1k6y
11359901 W.Li, F.C.Chang, and S.Desiderio (2001).
Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination.
  Mol Cell Biol, 21, 3935-3946.  
11343799 Y.Tsunaka, M.Haruki, M.Morikawa, and S.Kanaya (2001).
Strong nucleic acid binding to the Escherichia coli RNase HI mutant with two arginine residues at the active site.
  Biochim Biophys Acta, 1547, 135-142.  
10847684 A.K.Kennedy, D.B.Haniford, and K.Mizuuchi (2000).
Single active site catalysis of the successive phosphoryl transfer steps by DNA transposases: insights from phosphorothioate stereoselectivity.
  Cell, 101, 295-305.  
10880457 F.Lu, and N.L.Craig (2000).
Isolation and characterization of Tn7 transposase gain-of-function mutants: a model for transposase activation.
  EMBO J, 19, 3446-3457.  
11169922 J.Yi, and A.M.Skalka (2000).
Mapping epitopes of monoclonal antibodies against HIV-1 integrase with limited proteolysis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
  Biopolymers, 55, 308-318.  
10997908 L.Lai, H.Yokota, L.W.Hung, R.Kim, and S.H.Kim (2000).
Crystal structure of archaeal RNase HII: a homologue of human major RNase H.
  Structure, 8, 897-904.
PDB code: 1eke
10685051 R.D.Lins, T.P.Straatsma, and J.M.Briggs (2000).
Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding.
  Biopolymers, 53, 308-315.  
10450096 A.P.Eijkelenboom, R.Sprangers, K.Hård, R.A.Puras Lutzke, R.H.Plasterk, R.Boelens, and R.Kaptein (1999).
Refined solution structure of the C-terminal DNA-binding domain of human immunovirus-1 integrase.
  Proteins, 36, 556-564.
PDB code: 1qmc
10601033 D.R.Kim, Y.Dai, C.L.Mundy, W.Yang, and M.A.Oettinger (1999).
Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase.
  Genes Dev, 13, 3070-3080.  
  10074170 F.M.van den Ent, A.Vos, and R.H.Plasterk (1999).
Dissecting the role of the N-terminal domain of human immunodeficiency virus integrase by trans-complementation analysis.
  J Virol, 73, 3176-3183.  
10413462 J.Greenwald, V.Le, S.L.Butler, F.D.Bushman, and S.Choe (1999).
The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
  Biochemistry, 38, 8892-8898.
PDB codes: 1b92 1b9d 1b9f
10559232 J.L.Gerton, D.Herschlag, and P.O.Brown (1999).
Stereospecificity of reactions catalyzed by HIV-1 integrase.
  J Biol Chem, 274, 33480-33487.  
10547692 L.Haren, B.Ton-Hoang, and M.Chandler (1999).
Integrating DNA: transposases and retroviral integrases.
  Annu Rev Microbiol, 53, 245-281.  
10601032 M.A.Landree, J.A.Wibbenmeyer, and D.B.Roth (1999).
Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination.
  Genes Dev, 13, 3059-3069.  
10607294 M.Jaaskelainen, A.H.Mykkanen, T.Arna, C.M.Vicient, A.Suoniemi, R.Kalendar, H.Savilahti, and A.H.Schulman (1999).
Retrotransposon BARE-1: expression of encoded proteins and formation of virus-like particles in barley cells
  Plant J, 20, 413-422.  
  10585967 P.Hindmarsh, and J.Leis (1999).
Retroviral DNA integration.
  Microbiol Mol Biol Rev, 63, 836.  
10354426 R.D.Lins, J.M.Briggs, T.P.Straatsma, H.A.Carlson, J.Greenwald, S.Choe, and J.A.McCammon (1999).
Molecular dynamics studies on the HIV-1 integrase catalytic domain.
  Biophys J, 76, 2999-3011.  
10531491 Y.Li, Y.Yan, J.Zugay-Murphy, B.Xu, J.L.Cole, M.Witmer, P.Felock, A.Wolfe, D.Hazuda, M.K.Sardana, Z.Chen, L.C.Kuo, and V.V.Sardana (1999).
Purification, solution properties and crystallization of SIV integrase containing a continuous core and C-terminal domain.
  Acta Crystallogr D Biol Crystallogr, 55, 1906-1910.  
9646869 A.Wlodawer, and J.Vondrasek (1998).
Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.
  Annu Rev Biophys Biomol Struct, 27, 249-284.  
9813045 E.Krementsova, M.J.Giffin, D.Pincus, and T.A.Baker (1998).
Mutational analysis of the Mu transposase. Contributions of two distinct regions of domain II to recombination.
  J Biol Chem, 273, 31358-31365.  
9524133 E.L.Beall, and D.C.Rio (1998).
Transposase makes critical contacts with, and is stimulated by, single-stranded DNA at the P element termini in vitro.
  EMBO J, 17, 2122-2136.  
  9573274 J.L.Gerton, S.Ohgi, M.Olsen, J.DeRisi, and P.O.Brown (1998).
Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions.
  J Virol, 72, 5046-5055.  
9560188 J.Lubkowski, F.Yang, J.Alexandratos, A.Wlodawer, H.Zhao, T.R.Burke, N.Neamati, Y.Pommier, G.Merkel, and A.M.Skalka (1998).
Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor.
  Proc Natl Acad Sci U S A, 95, 4831-4836.
PDB codes: 1a5v 1a5w 1a5x
9830010 J.Lubkowski, F.Yang, J.Alexandratos, G.Merkel, R.A.Katz, K.Gravuer, A.M.Skalka, and A.Wlodawer (1998).
Structural basis for inactivating mutations and pH-dependent activity of avian sarcoma virus integrase.
  J Biol Chem, 273, 32685-32689.
PDB codes: 1vsk 1vsl 1vsm
  9573250 R.A.Lutzke, and R.H.Plasterk (1998).
Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding.
  J Virol, 72, 4841-4848.  
9649447 S.Y.Namgoong, and R.M.Harshey (1998).
The same two monomers within a MuA tetramer provide the DDE domains for the strand cleavage and strand transfer steps of transposition.
  EMBO J, 17, 3775-3785.  
9689049 Y.Goldgur, F.Dyda, A.B.Hickman, T.M.Jenkins, R.Craigie, and D.R.Davies (1998).
Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium.
  Proc Natl Acad Sci U S A, 95, 9150-9154.
PDB codes: 1bis 1biu 1biz
9164453 A.Wlodawer (1997).
Deposition of macromolecular coordinates resulting from crystallographic and NMR studies.
  Nat Struct Biol, 4, 173-174.  
9218451 G.Bujacz, J.Alexandratos, A.Wlodawer, G.Merkel, M.Andrake, R.A.Katz, and A.M.Skalka (1997).
Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity.
  J Biol Chem, 272, 18161-18168.
PDB codes: 1vsh 1vsi 1vsj
9325310 J.L.Gerton, and P.O.Brown (1997).
The core domain of HIV-1 integrase recognizes key features of its DNA substrates.
  J Biol Chem, 272, 25809-25815.  
9161051 M.Thomas, and L.Brady (1997).
HIV integrase: a target for AIDS therapeutics.
  Trends Biotechnol, 15, 167-172.  
8910309 A.Mazumder, N.Neamati, A.A.Pilon, S.Sunder, and Y.Pommier (1996).
Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site. Implications for the role of lysine 136 in DNA binding.
  J Biol Chem, 271, 27330-27338.  
8612279 H.Savilahti, and K.Mizuuchi (1996).
Mu transpositional recombination: donor DNA cleavage and strand transfer in trans by the Mu transposase.
  Cell, 85, 271-280.  
8702660 M.D.Andrake, and A.M.Skalka (1996).
Retroviral integrase, putting the pieces together.
  J Biol Chem, 271, 19633-19636.  
8994974 P.Heikinheimo, J.Lehtonen, A.Baykov, R.Lahti, B.S.Cooperman, and A.Goldman (1996).
The structural basis for pyrophosphatase catalysis.
  Structure, 4, 1491-1508.
PDB codes: 1wgi 1wgj
  8947057 R.J.Sarnovsky, E.W.May, and N.L.Craig (1996).
The Tn7 transposase is a heteromeric complex in which DNA breakage and joining activities are distributed between different gene products.
  EMBO J, 15, 6348-6361.  
8955106 S.Kanaya, M.Oobatake, and Y.Liu (1996).
Thermal stability of Escherichia coli ribonuclease HI and its active site mutants in the presence and absence of the Mg2+ ion. Proposal of a novel catalytic role for Glu48.
  J Biol Chem, 271, 32729-32736.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer